Amatu, Alessio
Somaschini, Alessio
Cerea, Giulio
Bosotti, Roberta
Valtorta, Emanuele
Buonandi, Pasquale
Marrapese, Giovanna
Veronese, Silvio
Luo, David
Hornby, Zachary
Multani, Pratik
Murphy, Danielle
Shoemaker, Robert
Lauricella, Calogero
Giannetta, Laura
Maiolani, Martina
Vanzulli, Angelo
Ardini, Elena
Galvani, Arturo
Isacchi, Antonella
Sartore-Bianchi, Andrea
Siena, Salvatore
Article History
Received: 17 July 2015
Revised: 12 October 2015
Accepted: 15 October 2015
First Online: 3 December 2015
Competing interests
: ASB is a consultant/advisory member for Amgen, Bayer, and Merck-Serono. SS is a consultant/advisory member for Amgen, Bayer, Eli-Lilly, Merck-Serono, Merus, Novartis, Roche, Sanofi, and Ignyta. DL, ZH, PM, DM, and RS are employees of Ignyta. AS, RB, EA, AG and AI are employees of Nerviano Medical Sciences. The remaining authors declare no conflict of interest.